A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects

NCT02692781 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: MOD-6031
OTHER: Placebo control

Sponsor

OPKO Health, Inc.

Collaborators

[object Object]